Indications
Infertility-
- Female infertility (e.g, Poor ovarian reserve and Polycystic ovary syndrome)
- Male infertility
Neurological disorders-
- Myopathy
- Ataxia
- Genetic Neuromuscular Disease
- Migraine
- Muscular Dystrophy
- Parkinson’s Disease
- Alzheimer’s Disease
Cardiovascular Disease-
- Congestive Heart Failure (CHF)
- Hypertension
- Angina
- Cardiomyopathy
- Heart Protection During Surge
Others-
- Periodontal Gum Disease
- Diabetes
- Exercise Performance
- Cancer
- Asthma
- Thyroid Disorder
Pharmacology
As Ubidecarenone is a lipophilic substance, it is absorbed less on an empty stomach and absorbed in greater amount when taken with food of high lipid content. Thus, after oral administration, Ubidecarenone is absorbed from the small intestine into the lymphatics system and then taken up by the liver where it is incorporated into lipoproteins and released into the blood circulation and at that time concentrated in the tissues.
Ubidecarenone is distributed to the various tissues of the body and is able to enter into the brain. The concentration varies from tissue to tissue and those with high rates of metabolic activity and high energy demands such as heart, muscle, liver, kidney and brain contain relatively high concentration of Ubidecarenone. Ubidecarenone is metabolized in all tissues in the body. Approximately 60% of an oral dose of Ubidecarenone is excreted in the feces. The main elimination of Ubidecarenone occurs with bile.
Dosage & Administration
For mitochondrial disorders: 150-160 mg, or 2 mg/kg/day.
For heart failure in adults: 100 mg per day divided into 2 or 3 doses.
For recent myocardial infarction: 120 mg daily in 2 divided doses.
For high blood pressure: 120-200 mg per day divided into 2 doses.
For isolated systolic hypertension: 60 mg twice daily.
For preventing migraine headache: 100 mg three times daily.
For Parkinson’s disease: 300 mg, 600 mg, 1200 mg and 2400 mg per day in 3-4 divided doses.
For infertility in men: 200-300 mg per day.
For muscular dystrophy: 100 mg per day.
Dividing the total daily dose by taking smaller amounts two or three times a day instead of a large amount all at once can help to reduce side effects.
Interaction
Warfarin: May reduce the effectiveness of warfarin.
Beta-blockers: Beta blockers (particularly propanolol) have been reported to inhibit some Ubidecarenone dependent enzymes,
Antidiabetic medications: May improve glycemic control in some type II diabetics. If this occurred, antidiabetic medications may need appropriate dose adjustment.
Doxorubicin: May help ameliorate the cardiotoxicity of doxorubicin।

Reviews
There are no reviews yet.